Post-Acute Sequelae of SARS-CoV-2 Infection (PASC) is a novel condition generally defined as new onset or persistence of symptoms related to SARS-CoV-2 beyond convalescence or first 30 days post-diagnosis. PASC has not been well defined by conditions or timeline manifestation. We measured PASC incidence in an integrated health system population (Kaiser Permanente Mid-Atlantic States; KPMAS) and provided supporting evidence for PASC-related conditions of focus (COF) identified from our previous research. Importantly, KPMAS is a closed healthcare system with high ascertainment of COVID-19 among our members, as well as PASC conditions and symptoms.
Using KPMAS electronic health records, we identified adult patients (?18 years) who had a SARS-CoV-2 RT-PCR test result (detected or undetected) from 1/1/2020 to 12/31/2020. We defined 3 diagnostic time intervals, predicated on the first test date of identified PASC phenotypes. These time intervals were defined as: T1) ‘Prevalent’: 4 years prior to PCR test identifying prevalent conditions; T2) ‘Acute/Persistent’: 0-30 days post-PCR and persisted in 30-120 day follow-up; T3) ‘Incident/Late’: 30-120 days post-PCR identifying incident conditions/symptoms. We enforced mutual exclusivity per patient by removing conditions and symptoms from T2 previously identified in T1 and those from T3 previously identified in T1 or T2. Diagnoses were grouped using Clinical Classification Software (CCS). The PCR-positive patients (cases) were matched to PCR-negative patients (controls) by month of test, age group, race, sex, and medical center. We prioritized 1:3 (case:control) matching, followed by 1:2, then 1:1. Risk ratios with 95% confidence intervals comparing case to control COF were calculated to determine significant COF.
Matching successfully resulted in 28,118 cases and 70,293 controls. Demographic differences were negligible and showed no association (Highest Cramer’s V: Age – .0511). Overall, risk of COF was 12% greater among cases than controls (Table 1). During T3, risk was significantly higher among cases for the following COF: anosmia, cardiac dysrhythmia, diabetes, genitourinary disorders, malaise, and nonspecific chest pain.
We delineated significant COF among those experiencing incident PASC in our KPMAS population. Our findings contribute to the overall evaluation of PASC and provide supporting evidence for an accepted definition. Further understanding the severity and duration of these conditions will be crucial.